Annual report pursuant to Section 13 and 15(d)

Acquisitions (Details 6)

v3.22.1
Acquisitions (Details 6) - USD ($)
12 Months Ended
Apr. 08, 2020
Dec. 31, 2021
Dec. 31, 2020
Business Acquisition [Line Items]      
Total estimated fair value of consideration     $ 0
Solo Sciences, Inc. [Member]      
Business Acquisition [Line Items]      
Common shares issued $ 17,550    
Contingent consideration 389    
Total estimated fair value of consideration $ 17,939 $ 0